Evidence map›Paper›PMID 35299870›Full record

ArticleToxicology reports2022

Genome-wide alteration of histone methylation profiles associated with cognitive changes in response to developmental arsenic exposure in mice.

Nicholas F Fitz, Aaron Barchowsky, Radosveta Koldamova, Iliya Lefterov

Open access · goldAbstract read
In one paragraph

Article in Toxicology reports, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.

0numbers the graph read from it
0cells of the map it votes in
5citing papers in PubMed
1.3field-weighted citation impact, top 23% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

5 citing papers in PubMed, 13 citations in OpenAlex.

  1. Article
  2. Review
  3. Effect of Gentianella acuta (Michx.) Hulten against the arsenic-induced development hindrance of mouse oocytes.Biometals : an international journal on the role of metal ions in biology, biochemistry, and medicine · 2024
    Article
  4. Article
  5. State of the Art of Genomic Technology in Toxicology: A Review.International journal of molecular sciences · 2023
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Nicholas F FitzDepartment of Environmental and Occupational Health, University of Pittsburgh, Pittsburgh, PA, United States.
Aaron BarchowskyDepartment of Environmental and Occupational Health, University of Pittsburgh, Pittsburgh, PA, United States.
Radosveta KoldamovaDepartment of Environmental and Occupational Health, University of Pittsburgh, Pittsburgh, PA, United States.
Iliya LefterovDepartment of Environmental and Occupational Health, University of Pittsburgh, Pittsburgh, PA, United States.
University of Pittsburgh · US

Funding

The interplay between Tau and ncRNAs – genomic and epigenomic clues to early AD pathogenesisR01AG077636 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI RADOSVETA KOLDAMOVA, ILIYA LEFTEROV · 2022 to 2026
$3.5M
APOE Orchestrated Molecular Signatures in Aging Brain and AD-the Contribution of APOE2R01AG057565 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KOLDAMOVA, RADOSVETA, LEFTEROV, ILIYA · 2018 to 2022
$3.2M
Age dependent APOE isoform specific effect on immune receptor mediated phagocytosis in brainRF1AG056371 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KOLDAMOVA, RADOSVETA, LEFTEROV, ILIYA · 2017 to 2018
$2.3M
APOE orchestrated ''molecular signatures'' in aging brain and AD - the contribution of APOE2R56AG057565 · NIA · UNIVERSITY OF PITTSBURGH AT PITTSBURGH · PI KOLDAMOVA, RADOSVETA, LEFTEROV, ILIYA · 2017 to 2017
$441k
NIA NIH HHS R01 AG057565NIA NIH HHS R01 AG077636NIA NIH HHS R56 AG057565NIA NIH HHS RF1 AG056371
6 · The paper itself

Abstract

Inorganic arsenic is a xenobiotic entering the body primarily through contaminated drinking water and food. There are defined mechanisms that describe arsenic's association with increased cancer incidence, however mechanisms explaining arsenic exposure and neurodevelopmental or aging disorders are poorly defined. In recent years, arsenic effects on epigenome have become a particular focus. We hypothesize that human relevant arsenic exposure during particular developmental windows, or long-term exposure later in life induce pathophysiological neural changes through epigenomic alterations, in particular histone methylation profile, manifesting as cognitive decline. C57BL/6 wild-type mice were continually exposed to sodium arsenite (100 µg/L) in drinking water prior to mating through weaning of the experimental progeny. A second cohort of aged APP/PS mice were chronically exposed to the same level of arsenic. Cognitive testing, histological examination of brains and genome-wide methylation levels of H3K4me3 and H3K27me3 examined after ChIP-seq were used to determine the effects of arsenic exposure. Developmental arsenic exposure caused significantly diminished cognition in wild-type mice. The analysis of ChIP-seq data and experiments with mouse embryonic stem cells demonstrated that epigenetic changes induced by arsenic exposure translated into gene expression alterations associated with neuronal development and neurological disease. Increased hippocampal amyloid plaques levels of APP/PS mice and cognitive decline provided evidence that arsenic exposure aggravated an existing Alzheimer's disease-like phenotype. We show developmental arsenic exposure significantly impacts histone modifications in brain which remain present into adulthood and provide a potential mechanism by which developmental arsenic exposure influences cognitive functions. We also show that human relevant, chronic arsenic exposure has deleterious effects on adult APP/PS mice and exacerbates existing Alzheimer's disease-like symptoms. The results demonstrate how developmental arsenic exposure impacts the brain epigenome, leading to altered gene expression later in life.

Indexed as

AD, Alzheimer’s diseaseAlzheimer’s diseaseArsenicCognitionDevelopmentEpigeneticsES, Embryonic Stem CellHistone methylationNOR, Novel Object RecognitionRWM, Radial Arm Water Maze

Identifiers

PMID35299870
PMCPMC8920871
OpenAlexW4220863400

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.